Pace Life Sciences Capabilities Update March 2026: Analytical Services

James Wheeler, Senior Director of Commercial Programs at Pace Life Sciences, presents an overview of the company’s 20-year evolution into a full-service CDMO supporting the pharmaceutical and biopharmaceutical industries. He highlights a comprehensive suite of services spanning CMC development, analytical testing, clinical trial material manufacturing, regulatory consulting, and facility support. Wheeler explains how the organization has grown through a combination of organic expansion and strategic acquisitions, building a nationwide network of GMP labs, manufacturing sites, and specialized centers of excellence. The presentation emphasizes strengths in analytical services, biologics, nucleic acids, and small molecules, along with advanced capabilities in packaging, extractables and leachables, and nitrosamine testing. With a strong focus on quality systems, data integrity, and client transparency, the company positions itself as a flexible, consultative partner dedicated to accelerating drug development from early research through commercialization.